PropertyValue
?:abstract
  • We have read with great interest the publication by Herman, et al , which reported occurrence of drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome (DiHS), in a COVID-19 patient:(1) the patient developed DiHS/DRESS 17~18 days after starting azithromycin and hydroxychloroquine
is ?:annotates of
?:creator
?:journal
  • J_Eur_Acad_Dermatol_Venereol
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Comment on \'Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19\': Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19
?:type
?:who_covidence_id
  • #793471
?:year
  • 2020

Metadata

Anon_0  
expand all